Literature DB >> 19660612

Relation of N-terminal pro-B-type natriuretic peptide to symptoms, severity, and left ventricular remodeling in patients with organic mitral regurgitation.

Mihael Potocki1, Johannes Mair, Michael Weber, Christian Hamm, Thilo Burkard, Renate Hiemetzberger, Klaus Peters, Nikolaus Jander, Thomas A Cron, Niklaus Hess, Andreas Hoffmann, Helmut Gekeler, Christa Gohlke-Bärwolf, Peter Buser, Christian Mueller.   

Abstract

Natriuretic peptides reflect cardiac stress and may therefore be useful in the management of patients with valvular heart disease. Data regarding these biomarkers in organic mitral regurgitation (MR) are sparse. In this study, 144 patients with moderate or severe organic MR were prospectively enrolled in an observational, multicenter study to analyze the relation of N-terminal-pro-B-type natriuretic peptide (NT-pro-BNP) to symptoms, severity of MR, and echocardiographic parameters. NT-pro-BNP levels (median 373 pg/ml, interquartile range 150 to 997) were associated with age, gender, creatinine, New York Heart Association (NYHA) functional class, atrial fibrillation, left ventricular (LV) end-systolic dimension, and the LV ejection fraction. Independent predictors of increased NT-pro-BNP levels were NYHA functional class (p = 0.003), atrial fibrillation (p = 0.005) and LV end-systolic dimension (p = 0.029). MR severity and left atrial dimension were not independently associated with NT-pro-BNP levels. NT-pro-BNP levels increased significantly with NYHA class (p <0.001) but not with MR severity (p = 0.144). NT-pro-BNP levels were significantly higher in symptomatic patients than in asymptomatic patients (582 pg/ml [interquartile range 246-1,360] vs 157 pg/ml [interquartile range 64 to 256], p <0.0001). The area under the receiver-operating characteristic curve to predict symptoms for NT-pro-BNP was 0.80 (95% confidence interval 0.71 to 0.88), which was significantly higher than for all echocardiographic variables (p <0.001 for all). In conclusion, NYHA functional class, atrial fibrillation, and LV end-systolic dimension are independent predictors of increased NT-pro-BNP levels in patients with moderate or severe organic MR. Therefore, NT-pro-BNP may be helpful in the clinical evaluation and management of patients with MR, especially when it is doubtful whether symptoms are related to MR or not.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19660612     DOI: 10.1016/j.amjcard.2009.04.023

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  4 in total

1.  Mitral Regurgitation and Serum N-Terminal Pro-Brain Natriuretic Peptide Levels in Children: A Modification of Adult Criteria.

Authors:  Elif Erolu; Figen Akalin
Journal:  Tex Heart Inst J       Date:  2022-07-01

2.  Plasma Brain Natriuretic Peptide (BNP) as an Indicator of Left Ventricular Function, Early Outcome and Mechanical Complications after Acute Myocardial Infarction.

Authors:  A Fazlinezhad; M Khadem Rezaeian; H Yousefzadeh; K Ghaffarzadegan; M Khajedaluee
Journal:  Clin Med Insights Cardiol       Date:  2011-08-30

Review 3.  Functional Role of Natriuretic Peptides in Risk Assessment and Prognosis of Patients with Mitral Regurgitation.

Authors:  Giovanna Gallo; Maurizio Forte; Rosita Stanzione; Maria Cotugno; Franca Bianchi; Simona Marchitti; Andrea Berni; Massimo Volpe; Speranza Rubattu
Journal:  J Clin Med       Date:  2020-05-05       Impact factor: 4.241

4.  B-type Natriuretic Peptide as an Index of Symptoms and Severity of Chronic Rheumatic Mitral Regurgitation.

Authors:  Eman M Abdel Fattah; Hany Younan Azer Girgis; Khaled El Khashab; Zeinab A Ashour; Ghada M Ezzat
Journal:  Heart Views       Date:  2016 Jan-Mar
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.